GTCbio is proud to present the 9th Immunotherapeutics & Immunomonitoring Conference, to be held on February 6-7, 2017 in San Diego, CA.
The immune system plays a central role not only in fighting infections, but also in many diseases and medical conditions, including cancer. Studies of the immune system has led to significant findings in many fields of medicine and biology, which has yielded the discovery of novel and unique substances and reagents that are now widely used for diagnosing, evaluating, and treating different malignant diseases. The development of prophylactic and therapeutic vaccines, and innovative combinatorial immunotherapeutic approaches, has substantially decreased mortality, increased life expectancy, improved life expectancy and improved the well-being of the millions of patients.
Leading scientific and clinical experts from academia and industry will present the latest findings and developments in the exciting area of immunotherapeutics and immunomonitoring. New immunological concepts with clinically translational implications will be discussed, along with evaluations of novel drug targets and therapeutic approaches, the role of biomarkers in immunomonitoring, and the latest data on combinatorial treatments in the clinic.
Network with colleagues to discuss updates on state-of-the-art immunomonitoring, novel strategies to identify and validate biomarkers predictive for clinical efficacy, novel strategies to identify and clinically develop synergistic combination therapies, and the outlook on novel druggable targets for immunotherapy.
9th Immunotherapeutics & Immunomonitoring
I. Emerging Targets in Immune Therapeutics
II. Conditioning the Tumor Microenviroment for Immunotherapy
III. Immunomonitoring & Novel High Throughput Technologies
IV. Combination Immunotherapy
The 2017 Organizing Committee